Navigation Links
Avery Biomedical Devices, Inc. Appoints Elefteriades to its Board of Directors
Date:10/15/2007

COMMACK, N.Y., Oct. 15 /PRNewswire/ -- It is with great privilege that Avery Biomedical Devices, Inc. (ABD) announces the appointment of John A. Elefteriades, M.D., F.A.C.S. to its Board of Directors.

Dr. Elefteriades is the William W.L. Glenn Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery at Yale University and Yale-New Haven Hospital. He serves as Co-Director of the Yale-New Haven Hospital Heart Center. He is recognized consistently in America's Top Doctors published by Castle Connolly. He serves on the Editorial Boards of the American Journal of Cardiology, Cardiology, The International Journal of Angiology, The Journal of Cardiac Surgery, and The Journal of Thoracic and Cardiovascular Surgery, among others. He has served on the Board of Governors of the American College of Cardiology and as President of the International College of Angiology. He has recently served on a steering committee for future research at the National Science Foundation.

Dr. Elefteriades has conducted award-winning pioneering research in cardiac surgery and has been instrumental in the development and testing of many medical devices, including ABD's phrenic nerve stimulator. He has published over 200 scientific papers and dozens of book chapters, as well as several textbooks of medicine and surgery. For the lay public, he has authored the recently published Your Heart: An Owner's Guide and the upcoming The Women's Heart: An Owner's Guide.

Linda Towler, CEO, states, "We are honored to have Dr. Elefteriades join our Board of Directors. His experience and expertise will be invaluable to the future growth of ABD."

Dr. Elefteriades states, "It is a privilege to serve on the Board of Directors of ABD. This company has served the world's need in diaphragm pacing. Exciting new products are under development in this and related arenas as well. I look forward to providing medical and surgical input to the Board."

ABOUT ABD

Avery Biomedical Devices, Inc. (ABD) is a privately-held biomedical device manufacturer located on Long Island, New York. It produces the breathing pacemaker: an implanted phrenic nerve stimulator which is used to free many quadriplegic and central hypoventilation patients from mechanical ventilation. Through its wholly-owned subsidiary, ABD Custom Manufacturing, Inc., ABD manufactures high-quality platinum contact electrodes for research projects, clinical trials and commercially distributed medical devices.

ABD is ISO-9001 certified, ISO-13485 compliant, and an FDA registered manufacturer of Class III medical devices.

Should you know a patient with quadriplegia, central sleep apnea or other condition that may benefit from a breathing pacemaker, or if you are interested in our ABD Custom products, please contact us.

CONTACT

Kenneth R. Aron, V. P. Sales & Marketing

631-864-1600

http://www.averybiomedical.com


'/>"/>
SOURCE Avery Biomedical Devices, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. UW Academic ADL Co-Lab joins worldwide effort against slavery
2. Biomedical engineering conference invites manufacturers
3. Manufacturing partnership will move into biotech and biomedical spaces
4. Biomedical Alliance about more than stem cells
5. Doyle seeks $2.5M for biomedical alliance
6. Students will show off biomedical devices to professors and investors
7. Biomedical alliance marks first full year
8. UW Biomedical Engineering awarded $2.9 million research grant
9. Having two biomedical tech centers in Wisconsin will help the state
10. New biomedical institute aims to unite business and academia in SE Wisconsin
11. Wisconsin publicly traded biomedical companies report gains this quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Summit for Stem Cell has received a $250,000 grant ... stem cell therapy for the treatment of Parkinson’s disease. The Summit research project is ... Scripps Research Institute in San Diego, CA. , The aim of of ...
(Date:4/28/2016)... Hill, Conn. (PRWEB) , ... April 28, 2016 ... ... of financing and ongoing support for Connecticut's innovative, growing companies, today announced the ... digital health and financial technology (fintech) companies. , “VentureClash looks to ...
(Date:4/27/2016)... ... 2016 , ... Shimadzu Scientific Instruments (SSI) will be showcasing ... Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for ... stop by booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC ...
(Date:4/27/2016)... ... 27, 2016 , ... The Board of Directors of Biohaven ... Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, Inc. ... responsible for the commercialization of multiple orphan drug indications. Mr. Tilton has ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):